Lawmaker Investigates FDA Involvement in Public-Private Partnership

Sen. Joe Manchin (D-W.Va.) is investigating whether a public-private industry partnership has corrupted FDA decisionmaking and improperly influenced agency attitudes on regulating painkillers. Citing reports that some drugmakers paid as much as $25,000 for entrée into the so-called Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), Manchin said the partnership appears to present a conflict of interest that allows companies to have “undue influence” over the FDA.
Drug Industry Daily